07:25 AM EDT, 08/11/2025 (MT Newswires) -- Biohaven ( BHVN ) reported a Q2 non-GAAP net loss Monday of $1.63 per diluted share, narrowing from a loss of $3.52 a year earlier.

Analysts polled by FactSet expected a loss of $1.69.

The company did not report any revenue for the quarter ended June 30, as expected.

Biohaven ( BHVN ) said it had about $408.2 million in cash, cash equivalents, marketable securities and restricted cash as of June 30.

The company's shares were down 1.2% in recent premarket activity.